Announcement on Voluntary Disclosure of National Institute for Health and Care Excellence's Recommendation of Baiyueze (Zanubrutinib Capsules) for Treatment of Adult Patients with Chronic Lymphocytic Leukemia
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment